Maria Voronkov

Maria Voronkov

Auto-generated profile, based on publicly available information

Maria Voronkov

National Institute for Health and Care Research Oxford Health Biomedical Research Centre and John Radcliffe Hospital; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
HPHua Pu
Hua Pu
LBLaura C. Bailey
Laura C. Bailey
LBLudwig G. Bauer
Ludwig G. Bauer
MVMaria Voronkov
Maria Voronkov
MBMatthew Baxter
Matthew Baxter
FRFraydoon Rastinejad
Fraydoon Rastinejad
The basic helix–loop–helix PER-ARNT-SIM (bHLH-PAS) proteins BMAL1 and CLOCK heterodimerize to form the master transcription factor governing rhythmic gene expression. Owing to connections between circadian regulation and numerous physiological pathways, targeting the BMAL1–CLOCK complex pharmacologically is an attractive entry point for intervening in circadian-related processes. In this study, we developed a small molecule, Core Circadian Modulator (CCM), that targets the cavity in the PASB domain of BMAL1, causing it to expand, leading to conformational changes in the PASB domain and altering the functions of BMAL1 as a transcription factor. Biochemical, structural and cellular investigations validate the high level of selectivity of CCM in engaging BMAL1, enabling direct access to BMAL1–CLOCK cellular activities. CCM induces dose-dependent alterations in PER2–Luc oscillations and orchestrates the downregulation of inflammatory and phagocytic pathways in macrophages. These findings collectively reveal that the BMAL1 protein architecture is inherently configured to enable the binding of chemical ligands for functional modulation.

15 January 2020 in eLife
Verified
Journal Article
Open access
MBMatthew Baxter
Matthew Baxter
MVMaria Voronkov
Maria Voronkov
TPToryn Poolman
Toryn Poolman
GGGina Galli
Gina Galli
CPChristian Pinali
Christian Pinali
DRDavid Ray
David Ray
Efficient mitochondrial function is required in tissues with high energy demand such as the heart, and mitochondrial dysfunction is associated with cardiovascular disease. Expression of mitochondrial proteins is tightly regulated in response to internal and external stimuli. Here we identify a novel mechanism regulating mitochondrial content and function, through BUD23-dependent ribosome generation. BUD23 was required for ribosome maturation, normal 18S/28S stoichiometry and modulated the translation of mitochondrial transcripts in human A549 cells. Deletion of Bud23 in murine cardiomyocytes reduced mitochondrial content and function, leading to severe cardiomyopathy and death. We discovered that BUD23 selectively promotes ribosomal interaction with low GC-content 5’UTRs. Taken together we identify a critical role for BUD23 in bioenergetics gene expression, by promoting efficient translation of mRNA transcripts with low 5’UTR GC content. BUD23 emerges as essential to mouse development, and to postnatal cardiac function.

19 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
NMNoelia Martínez-Sánchez
Noelia Martínez-Sánchez
ABAnneke Brümmer
Anneke Brümmer
NBNichola J. Barron
Nichola J. Barron
MVMaria Voronkov
Maria Voronkov
DRDaniel B. Rosoff
Daniel B. Rosoff
DBDavid A. Bechtold
David A. Bechtold
Summary: Efficient energy metabolism is essential for health and its dysregulation drives cardiometabolic disease. Delivery of regulatory control through translation and ribosome function is emerging as important. Here, we identify the rRNA methyltransferase BUD23 as a potent regulator of cellular and systemic energy homeostasis. Adipocyte-specific deletion of BUD23 in mice regulates lipid and mitochondrial metabolism resulting in a pronounced lean phenotype and resistance to diet-induced obesity. Mechanistically, BUD23 modulates translation initiation and efficiency of mRNAs with specific features – including short 5’ UTR length and GC-rich post-initiation codon usage – characteristic of mitochondrial and lipogenic proteins. Genetic analyses and Mendelian randomisation support a role for BUD23 in human cardiometabolic traits and disease burden. Together, our findings uncover a conserved translational control mechanism that regulates energy state, from cellular metabolism through to human cardiometabolic health.

2 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LGLily A. Gates
Lily A. Gates
DBDustin C. Bagley
Dustin C. Bagley
KKKonstantinos Kalyviotis
Konstantinos Kalyviotis
JFJohn Fadul
John Fadul
TATania Auchynnikava
Tania Auchynnikava
JRJody Rosenblatt
Jody Rosenblatt
During homeostasis, crowded cells with the lowest energy levels are eliminated by extrusion via Piezo1 signalling to maintain constant cell numbers. However, crowding-induced extrusion does not necessarily remove damaged or otherwise unfit cells. Here, we show that glucose or glutamine starvation triggers a rapid, regulated wave of extrusion, called starvation-induced cell extrusion (STICE), that selectively eliminates cells bearing DNA damage markers via a p53-dependent, Piezo1-independent pathway, improving monolayer fitness. Unlike non-extruding cells, which recycle contents through autophagy and lysosomal digestion, p53-activated cells instead use LC3 to drive lysosomal exocytosis, promoting extrusion signalling. By eliminating defective and transformed cells, STICE confers resistance to damage and apoptotic stimuli in the remaining monolayer. STICE thus acts as a tissue-level analogue of autophagy: rather than improving individual cells by digesting and recycling damaged components, it improves tissue fitness by eliminating substandard cells.